EMEA-002168-PIP01-17-M02

Key facts

Active substance
Onasemnogenum abeparvovecum
Therapeutic area
Neurology
Decision number
P/0315/2019
PIP number
EMEA-002168-PIP01-17-M02
Pharmaceutical form(s)
Solution for injection/infusion
Condition(s) / indication(s)
Treatment of spinal muscular atrophy
Route(s) of administration
  • Intravenous use
  • Intrathecal use
Contact for public enquiries
AveXis EU Ltd

Tel. +351 308800322
E-mail: Medinfo.emea@avexis.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating